-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
-
Summary
-
Aerovate Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2022 to Q3 2025.
- Aerovate Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2025 was -86.7 %, a 56.7% decline year-over-year.
- Aerovate Therapeutics, Inc. annual Return On Assets for 2024 was -72.9 %, a 32.3% decline from 2023.
- Aerovate Therapeutics, Inc. annual Return On Assets for 2023 was -55.1 %, a 61.9% decline from 2022.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)